Becker's Healthcare December 28, 2021
Naomi Diaz

The FDA issued a draft guidance Dec. 23 detailing how digital health technology can be used to capture data remotely from patients in clinical trials.

The guidance provides recommendations to sponsors, investigators and stakeholders on the use of digital health technologies and how they can facilitate the use of them in clinical investigations.

The recommendation addresses these...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Technology
FDA approves Lumicell’s breast cancer imaging tool
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Opinion: An FDA pathway can accelerate innovation for Duchenne muscular dystrophy
What principles should guide artificial intelligence innovation in healthcare?
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer

Share This Article